Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia

Aim. To evaluate the compliance and virological response to pegylated interferon alpha 2a treatment of chronic hepatitis B in Roma population compared to majority Caucasian population in Slovakia. Methods. Retrospective evaluation of a cohort of all Roma patients treated with pegylated interferon al...

Full description

Saved in:
Bibliographic Details
Main Authors: Sylvia Drazilova, Martin Janicko, Pavol Kristian, Ivan Schreter, Branislav Kucinsky, Marek Kozlej, Ivana Hockickova, Peter Jarcuska
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2016/8682494
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850174025803759616
author Sylvia Drazilova
Martin Janicko
Pavol Kristian
Ivan Schreter
Branislav Kucinsky
Marek Kozlej
Ivana Hockickova
Peter Jarcuska
author_facet Sylvia Drazilova
Martin Janicko
Pavol Kristian
Ivan Schreter
Branislav Kucinsky
Marek Kozlej
Ivana Hockickova
Peter Jarcuska
author_sort Sylvia Drazilova
collection DOAJ
description Aim. To evaluate the compliance and virological response to pegylated interferon alpha 2a treatment of chronic hepatitis B in Roma population compared to majority Caucasian population in Slovakia. Methods. Retrospective evaluation of a cohort of all Roma patients treated with pegylated interferon alpha 2a from 2007 to 2013 in 3 centers for treatment of chronic viral hepatitis B. The Study included 43 Roma patients with chronic viral hepatitis B and randomly selected control group. Treatment duration was 48 weeks. Viral response was evaluated after 24 weeks, at the end of treatment, and 24 weeks after the end of treatment. Results. Complete treatment course was finished by 79.1% of Roma patients compared to all patients from the control group p=0.0009. There was a tendency toward lower viral response rate in Roma at all time points; however significant difference was only at end of treatment viral response (51.2% Roma versus 81.4% majority, p=0.003). We also did not find significant difference at the rate of HBsAg loss. Conclusion. Roma patients with chronic hepatitis B have significantly worse compliance to treatment with pegylated interferon and they have significantly lower rate of end of treatment viral response.
format Article
id doaj-art-c6e963ccf72d49a09a8774fe75ff4e52
institution OA Journals
issn 1687-6121
1687-630X
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-c6e963ccf72d49a09a8774fe75ff4e522025-08-20T02:19:44ZengWileyGastroenterology Research and Practice1687-61211687-630X2016-01-01201610.1155/2016/86824948682494Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern SlovakiaSylvia Drazilova0Martin Janicko1Pavol Kristian2Ivan Schreter3Branislav Kucinsky4Marek Kozlej5Ivana Hockickova6Peter Jarcuska7Department of Internal Medicine, Poprad Hospital, Banícka 28, 05845 Poprad, Slovakia1st Department of Internal Medicine, Medical Faculty of Pavol Jozef Šafárik University in Košice, Trieda SNP 1, 04001 Košice, SlovakiaDepartment of Infectology and Travel Medicine, Medical Faculty of Pavol Jozef Šafárik University in Košice, Trieda SNP 1, 04001 Košice, SlovakiaDepartment of Infectology and Travel Medicine, Medical Faculty of Pavol Jozef Šafárik University in Košice, Trieda SNP 1, 04001 Košice, Slovakia1st Department of Internal Medicine, Medical Faculty of Pavol Jozef Šafárik University in Košice, Trieda SNP 1, 04001 Košice, Slovakia1st Department of Internal Medicine, Medical Faculty of Pavol Jozef Šafárik University in Košice, Trieda SNP 1, 04001 Košice, SlovakiaDepartment of Infectology and Travel Medicine, Medical Faculty of Pavol Jozef Šafárik University in Košice, Trieda SNP 1, 04001 Košice, Slovakia1st Department of Internal Medicine, Medical Faculty of Pavol Jozef Šafárik University in Košice, Trieda SNP 1, 04001 Košice, SlovakiaAim. To evaluate the compliance and virological response to pegylated interferon alpha 2a treatment of chronic hepatitis B in Roma population compared to majority Caucasian population in Slovakia. Methods. Retrospective evaluation of a cohort of all Roma patients treated with pegylated interferon alpha 2a from 2007 to 2013 in 3 centers for treatment of chronic viral hepatitis B. The Study included 43 Roma patients with chronic viral hepatitis B and randomly selected control group. Treatment duration was 48 weeks. Viral response was evaluated after 24 weeks, at the end of treatment, and 24 weeks after the end of treatment. Results. Complete treatment course was finished by 79.1% of Roma patients compared to all patients from the control group p=0.0009. There was a tendency toward lower viral response rate in Roma at all time points; however significant difference was only at end of treatment viral response (51.2% Roma versus 81.4% majority, p=0.003). We also did not find significant difference at the rate of HBsAg loss. Conclusion. Roma patients with chronic hepatitis B have significantly worse compliance to treatment with pegylated interferon and they have significantly lower rate of end of treatment viral response.http://dx.doi.org/10.1155/2016/8682494
spellingShingle Sylvia Drazilova
Martin Janicko
Pavol Kristian
Ivan Schreter
Branislav Kucinsky
Marek Kozlej
Ivana Hockickova
Peter Jarcuska
Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
Gastroenterology Research and Practice
title Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
title_full Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
title_fullStr Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
title_full_unstemmed Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
title_short Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
title_sort lower viral response to pegylated interferon alpha 2a treatment of chronic hepatitis b in roma people in eastern slovakia
url http://dx.doi.org/10.1155/2016/8682494
work_keys_str_mv AT sylviadrazilova lowerviralresponsetopegylatedinterferonalpha2atreatmentofchronichepatitisbinromapeopleineasternslovakia
AT martinjanicko lowerviralresponsetopegylatedinterferonalpha2atreatmentofchronichepatitisbinromapeopleineasternslovakia
AT pavolkristian lowerviralresponsetopegylatedinterferonalpha2atreatmentofchronichepatitisbinromapeopleineasternslovakia
AT ivanschreter lowerviralresponsetopegylatedinterferonalpha2atreatmentofchronichepatitisbinromapeopleineasternslovakia
AT branislavkucinsky lowerviralresponsetopegylatedinterferonalpha2atreatmentofchronichepatitisbinromapeopleineasternslovakia
AT marekkozlej lowerviralresponsetopegylatedinterferonalpha2atreatmentofchronichepatitisbinromapeopleineasternslovakia
AT ivanahockickova lowerviralresponsetopegylatedinterferonalpha2atreatmentofchronichepatitisbinromapeopleineasternslovakia
AT peterjarcuska lowerviralresponsetopegylatedinterferonalpha2atreatmentofchronichepatitisbinromapeopleineasternslovakia